Digital Cognitive Behavioral Therapy App Aids Anxiety
By Lori Solomon HealthDay Reporter
TUESDAY, Aug. 27, 2024 -- A cognitive behavioral therapy (CBT) app is efficacious in improving symptoms in young adults with anxiety disorders, according to a study published online Aug. 20 in JAMA Network Open.
Jennifer N. Bress, Ph.D., from Weill Cornell Medicine in New York City, and colleagues investigated the efficacy of and engagement with Maya, a scalable, self-guided, comprehensive mobile CBT intervention. The analysis included 59 participants who received six weeks of the intervention and were randomly assigned to one of three different text message-based incentive conditions (gain-framed, loss-framed, or gain-social support).
The researchers found that anxiety, measured by the Hamilton Anxiety Rating Scale, decreased across conditions from baseline to the end of the intervention (mean difference, −5.64), and symptomatic improvement was maintained at the week 12 follow-up (baseline to follow-up mean difference, −5.67). Change in anxiety did not differ by incentive condition. A similar pattern of improvement was seen for secondary anxiety measures (Anxiety Sensitivity Index and Liebowitz Social Anxiety Scale scores), with no evidence of differences between incentive conditions. Participants completed a mean of 10.8 of 12 sessions. At all study visits, the User Mobile Application Rating Scale app quality ratings exceeded the published threshold for acceptability, with no evidence that either session completion or app quality ratings differed by incentive condition.
"The findings of this study suggest that self-guided mobile cognitive behavioral therapy apps can be efficacious in improving anxiety symptoms, regardless of the type of incentive strategy used to promote engagement," the authors write.
Several authors disclosed ties to the medical technology industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Hydrops MRI Accurately Differentiates Meniere Disease, Vestibular Migraine
MONDAY, June 23, 2025 -- The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately...
Gluten-Stimulated Interleukin-2 Secretion Useful for Diagnosing Celiac Disease
MONDAY, June 23, 2025 -- Gluten-stimulated interleukin-2 (IL-2) secretion is useful for diagnosis of celiac disease (CeD), according to a study published online June 9 in...
Minor Complications Up for Black Patients After Weight-Loss Surgery
MONDAY, June 23, 2025 -- Black patients have a higher incidence of minor complications after metabolic and bariatric surgery, according to a study presented at the annual meeting...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.